Vitamin D and K Supplementation Is Associated with Changes in the Methylation Profile of U266-Multiple Myeloma Cells, Influencing the Proliferative Potential and Resistance to Bortezomib
Multiple myeloma (MM) is a plasma cell malignancy that, despite recent advances in therapy, continues to pose a major challenge to hematologists. Currently, different classes of drugs are applied to treat MM, among others, proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies. Mos...
Main Authors: | Karolina Łuczkowska, Piotr Kulig, Bartłomiej Baumert, Bogusław Machaliński |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/16/1/142 |
Similar Items
-
5-Aza-2′-Deoxycytidine Alters the Methylation Profile of Bortezomib-Resistant U266 Multiple Myeloma Cells and Affects Their Proliferative Potential
by: Karolina Łuczkowska, et al.
Published: (2023-11-01) -
The Evidence That 25(OH)D3 and VK2 MK-7 Vitamins Influence the Proliferative Potential and Gene Expression Profiles of Multiple Myeloma Cells and the Development of Resistance to Bortezomib
by: Karolina Łuczkowska, et al.
Published: (2022-12-01) -
Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development
by: Karolina Łuczkowska, et al.
Published: (2022-02-01) -
Epigenetic Alterations as Vital Aspects of Bortezomib Molecular Action
by: Piotr Kulig, et al.
Published: (2023-12-01) -
Vitamin D as a Potential Player in Immunologic Control over Multiple Myeloma Cells: Implications for Adjuvant Therapies
by: Piotr Kulig, et al.
Published: (2022-04-01)